IRCT20211014052767N1招募中3 期
Comparison of the therapeutic effects of pioglitazone and metformin in non-alcoholic fatty liver disease
Oroumia University of Medical Sciences0 个研究点目标入组 110 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Grade 2 and 3 non-alcoholic fatty liver disease based on the latest ultrasound findings
排除标准
- •History of long term alcohol consumption
- •History chronic and acute viral and autoimmune hepatitis, type 1 diabetes, cholestatic diseases including cholecystitis, kidney, thyroid disease, various malignancies, severe infectious diseases, cardiovascular disease and immune deficiency
- •History of pioglitazone, metformin, NSAIDs, fibrates, statins and warfarin
- •Pregnancy and lactation
- •History of corticosteroids and steroid compounds in the last three months
- •Controlled diet or strenuous exercise
研究者
相似试验
已完成
不适用
Clinical investigation of the effects of pioglitazone in the diabetic patients with hemodilaysisDiabetic patients with hemodialysisJPRN-UMIN000002643ihon University Nerima Hikarigaoka Hospital60
已完成
3 期
comparison the therapeutic effect of pioglitazone and carnitine to pioglitazone and vitamin E in patients with non alcoholic fatty liver diseaseIRCT20190701044062N8Tabriz University of Medical Sciences80
已完成
3 期
Effect of metformin and pioglitazon in treatment of fatty liverIRCT20150706023083N2Tabriz University of Medical Sciences68
招募中
3 期
comparison the teraputic effect of pioglitazone and carnitine to metformin and carnitine in patients with non alcoholic fatty liver diseasenon alcoholic fatty liver disease (NAFLD).Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20190701044062N3Tabriz University of Medical Sciences80
招募中
3 期
Effect of Pioglitazone and ClobetasolIRCT20210926052596N1Tehran University of Medical Sciences40